2024
DOI: 10.55730/1300-0152.2678
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic gene biomarkers for c-Src inhibitor Si162 sensitivity in melanoma cells

Seyhan TÜRK,
Ayşegül YILMAZ,
Ümit Yavuz MALKAN
et al.

Abstract: Background/aim Early detection and treatment are crucial in combating malignant melanoma. Src is an important therapeutic target in melanoma due to its association with cancer progression. However, developing effective Src-targeting drugs remains challenging and personalized medicine relies on biomarkers and targeted therapies for precise and effective treatment. This study focuses on Si162, a newly synthesized c-Src inhibitor, to identify reliable biomarkers for predicting Si162 sensitivity and e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 25 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?